Generated: April 29, 2017
|Title:||Method for prolonging the inhibitory effect of saralasin on angiotensin II|
|Abstract:||The angiotensin II inhibition by saralasin is prolonged by its subcutaneous administration in the form of a gel.|
|Inventor(s):||Fulton; Robert W. (Hamilton, NY)|
|Assignee:||Morton-Norwich Products, Inc. (Norwich, NY)|
|Patent Claims:||1. The method of prolonging the antihypertensive effect of saralasin to angiotensin II in animals which consists in administering subcutaneously to angiotensin II hypertensive animals a composition consisting of saralasin in a 15% gelatin gel in an amount to deliver a dose of saralasin of about 5 mg/kg.|
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.